X-37805077-G-C
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM2PM5PP3_StrongPP5_Moderate
The NM_000397.4(CYBB):c.1223G>C(p.Gly408Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G408E) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000397.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYBB | NM_000397.4 | c.1223G>C | p.Gly408Ala | missense_variant | 10/13 | ENST00000378588.5 | NP_000388.2 | |
CYBB | XM_047441855.1 | c.917G>C | p.Gly306Ala | missense_variant | 9/12 | XP_047297811.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYBB | ENST00000378588.5 | c.1223G>C | p.Gly408Ala | missense_variant | 10/13 | 1 | NM_000397.4 | ENSP00000367851 | P1 | |
CYBB | ENST00000696171.1 | c.1127G>C | p.Gly376Ala | missense_variant | 9/12 | ENSP00000512462 | ||||
CYBB | ENST00000696170.1 | c.*732G>C | 3_prime_UTR_variant, NMD_transcript_variant | 9/12 | ENSP00000512461 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD3 exomes AF: 0.00000547 AC: 1AN: 182884Hom.: 0 AF XY: 0.0000148 AC XY: 1AN XY: 67560
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Granulomatous disease, chronic, X-linked Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2021 | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Gly408 amino acid residue in CYBB. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 29560547, 9585602, 10627478, 8634410). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CYBB protein function. This variant has not been reported in the literature in individuals with CYBB-related conditions. This variant is present in population databases (rs151344474, ExAC 0.01%). This sequence change replaces glycine with alanine at codon 408 of the CYBB protein (p.Gly408Ala). The glycine residue is highly conserved and there is a small physicochemical difference between glycine and alanine. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at